Which startups have raised the most funding in the mental health market?
Download our beautiful pitch about the mental health market

In our mental health market deck, you will find everything you need to understand the market
The mental health market has attracted billions of dollars across psychiatric drug development, virtual care, addiction treatment, digital therapeutics, behavioral health infrastructure, autism care and specialized clinical services.
To make this fragmented market easier to follow, we rank mental health startups by the cumulative amount of funding raised and update this list every month as new financing rounds are announced.
The ranking shows a highly concentrated market where a small group of heavily funded biotechnology and care-delivery companies sits above a long tail of specialized mental health startups.
And if you want to better understand this new industry, you can download our pitch covering the mental health market.
A quick summary table
| Metric | Value |
|---|---|
| Most funded mental health startup | atai Life Sciences / AtaiBeckley, $872M |
| Second most funded mental health startup | MindMed, $641M |
| Largest mental health funding round | MindMed, $259M public offering in October 2025 |
| Median mental health startup funding | $56M |
| Share of mental health funding captured by the top 10 | About 44% |
| Median time since last funding round | About 32 months |
| Mental health startups funded in the last 12 months | 19 |
| Total mental health funding tracked | About $8.34B |
| Mental health startups above $100M raised | 29 |
| Psychedelic and adjacent mental health funding | About $2.29B across 13 selected companies |

This chart, featured in our mental health market deck, illustrates yearly VC investment in mental health startups
Top startups in the mental health market ranked by total funding raised
Here is an updated table that ranks the top startups in the mental health market based on the total amount of funding they have raised to date.
The table also includes the total number of funding rounds, the date and size of the latest round, the financing type (e.g. Series A, equity financing), key investors, the startup’s current status (active, IPO, acquired, or shut down), and a confidence score based on the data collected (we excluded startups with very low data confidence, to make sure everything is reliable).
If you're interested in knowing how much these startups are worth, you can check our list of the top startups in the mental health market ranked by valuation.
| # | Startup | What They Do | Total Raised ($) | Total Rounds | Last Round Date | Last Round Amount ($) | Last Round Type | Key Investors | Current Stage | Confidence |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | atai Life Sciences / AtaiBeckley | Novel psychiatric drug treatments | $872M | 8 | October 2025 | $150M | Public Offering | Berenberg, Ferring Ventures, Apeiron | IPO | Strong |
| 2 | MindMed | Psychedelic-inspired psychiatric medicines | $641M | 10 | October 2025 | $259M | Public Offering | Jefferies, Leerink Partners, Evercore ISI | IPO | Strong |
| 3 | Cybin | Psychedelic medicines for psychiatric disorders | $454M | 8 | October 2025 | $175M | Registered Direct Offering | Venrock, OrbiMed, Point72 | IPO | Partial |
| 4 | Akili Interactive | Digital therapeutics for cognitive disorders | $392M | 5 | August 2022 | $162M | PIPE | Social Capital, Suvretta Capital, Apeiron | Acquired | Strong |
| 5 | Cortica | Integrated autism and neurodevelopmental care | $255M | 7 | November 2024 | $80M | Series E / Strategic | Morgan Health, Nexus NeuroTech Ventures, Autism Impact Fund | Active | Partial |
| 6 | Alma | Therapist insurance and practice platform | $221M | 5 | August 2022 | $130M | Series D | Thoma Bravo, Cigna Ventures, Insight Partners | Active | Full |
| 7 | Bright Minds Biosciences | Serotonergic therapies for brain disorders | $218M | 6 | January 2026 | $175M | Public Offering | Jefferies, TD Securities, Piper Sandler | IPO | Strong |
| 8 | Cognito Therapeutics | Noninvasive Alzheimer’s neurostimulation therapy | $213M | 3 | March 2026 | $105M | Series C | Morningside Ventures, IAG Capital Partners, Starbloom Capital | Active | Partial |
| 9 | Brightline | Pediatric virtual behavioral healthcare | $205M | 5 | July 2022 | $10M | Series C Extension | Northwell Health | Active | Full |
| 10 | Draig Therapeutics | Drugs for neuropsychiatric disorders | $205M | 3 | July 2026 | $65M | Series B | Deep Track Capital, Janus Henderson, Marshall Wace | Active | Strong |
| 11 | SonderMind | Therapy marketplace and care platform | $183M | 4 | July 2021 | $150M | Series C | Drive Capital, Premji Invest, General Catalyst | Active | Strong |
| 12 | Click Therapeutics | Prescription digital therapeutics platform | $181M | 7 | April 2026 | $50M | Series D | Boehringer Ingelheim | Active | Strong |
| 13 | Wayspring | Value-based substance use disorder care | $161M | 7 | May 2024 | $45M | Growth / Series D Extension | CVS Health Ventures, Valtruis, .406 Ventures | Active | Strong |
| 14 | Delix Therapeutics | Non-hallucinogenic neuroplasticity drugs | $155M | 3 | August 2026 | $85M | Series C | Johnson & Johnson Development Corporation | Active | Partial |
| 15 | Big Health | Prescription digital mental health treatments | $154M | 6 | February 2026 | $24M | Strategic / Growth | .406 Ventures, AlleyCorp, CVS Health Ventures | Active | Strong |
| 16 | Lykos Therapeutics | MDMA-assisted therapy for PTSD | $150M | 2 | May 2025 | $50M | Series B | Gracias Family Foundation, CH Foundation | Active | Strong |
| 17 | Pelago | Digital substance use clinic | $150M | 5 | March 2024 | $58M | Series C | Atomico, Kinnevik, Eight Roads Ventures | Active | Full |
| 18 | Beckley Psytech | Short-duration psychedelic psychiatric medicines | $148M | 5 | January 2024 | $40M | Series C | atai Life Sciences | Acquired | Strong |
| 19 | Workit Health | Addiction treatment via telehealth | $131M | 4 | October 2021 | $118M | Series C | Insight Partners, CVS Health Ventures, FirstMark Capital | Active | Full |
| 20 | Eleos Health | AI documentation for behavioral healthcare | $128M | 5 | January 2025 | $60M | Series C | Greenfield Partners, F-Prime Capital, Eight Roads | Active | Full |
| 21 | Eleanor Health | Outpatient addiction and mental healthcare | $115M | 5 | October 2024 | $30M | Series D | General Catalyst, Town Hall Ventures, Echo Health Ventures | Active | Strong |
| 22 | Author Health | Senior serious-mental-illness care | $115M | 1 | June 2023 | $115M | Growth Equity | General Atlantic, Flare Capital Partners | Active | Full |
| 23 | Brightside Health | Virtual psychiatric care platform | $114M | 5 | March 2024 | $33M | Series C | S32, Kennedy Lewis, Time BioVentures | Active | Strong |
| 24 | Happify Health / Twill | Digital behavioral health therapeutics platform | $113M | 6 | March 2021 | $73M | Series D | Deerfield Management, ION Crossover Partners, Omega Capital | Acquired | Partial |
| 25 | Woebot Health | AI conversational mental health support | $108M | 3 | March 2022 | $10M | Strategic Venture | Leaps by Bayer | Active | Partial |
| 26 | Octave | Outcomes-based mental healthcare network | $106M | 4 | June 2023 | $52M | Series C | Cigna Ventures, Novo Holdings, Avidity Partners | Active | Strong |
| 27 | Holmusk | Behavioral health data analytics | $106M | 5 | October 2023 | $30M | Series B Extension | Veradigm, Health Catalyst Capital, Heritas Capital | Active | Partial |
| 28 | Two Chairs | Technology-enabled therapy provider | $104M | 4 | April 2024 | $72M | Series C | Amplo, Fifth Down Capital | Active | Strong |
| 29 | Bicycle Health | Virtual opioid addiction treatment | $104M | 5 | January 2025 | $17M | Series C / Venture | Questa Capital, SignalFire, Frist Cressey Ventures | Active | Strong |
| 30 | InStride Health | Pediatric anxiety and OCD treatment | $86M | 3 | June 2026 | $30M | Series C | Echo Health Ventures, FMZ Ventures, .406 Ventures | Active | Strong |
| 31 | Boulder Care | Virtual addiction treatment and recovery | $85M | 4 | May 2024 | $35M | Series C | Advance Venture Partners, First Round Capital, Qiming Venture Partners USA | Active | Full |
| 32 | NOCD | OCD-focused virtual therapy | $84M | 4 | January 2023 | $34M | Series C | 7wire Ventures, Cigna Ventures, Eight Roads Ventures | Active | Strong |
| 33 | Valera Health | Virtual high-acuity behavioral healthcare | $79M | 7 | April 2024 | $9M | Equity Financing | Undisclosed | Acquired | Partial |
| 34 | ieso | AI-powered digital therapy | $78M | 3 | November 2021 | $53M | Series B | Morningside, Sony Innovation Fund, IP Group | Acquired | Strong |
| 35 | Tava Health | Virtual behavioral healthcare platform | $73M | 4 | April 2026 | $40M | Series C | Centana Growth Partners, Catalyst Investors, Peterson Ventures | Active | Full |
| 36 | Gilgamesh Pharmaceuticals | Novel neuropsychiatric psychedelic drugs | $68M | 4 | December 2022 | $39M | Series B | Prime Movers Lab, Satori Capital, Alumni Ventures | Acquired | Strong |
| 37 | Ophelia | Online opioid addiction treatment | $68M | 3 | December 2021 | $50M | Series B | Tiger Global, Menlo Ventures, General Catalyst | Active | Full |
| 38 | aptihealth | Higher-acuity behavioral healthcare | $61M | 3 | April 2023 | $11M | Series B Extension | H/L Ventures, Takeda Digital Ventures | Active | Strong |
| 39 | Numinus | Psychedelic mental-health services and research | $59M | 6 | February 2024 | $4M | Public Offering | Eight Capital, Stifel GMP, Integrated V.C. | IPO | Strong |
| 40 | Cartwheel Care | School-based pediatric mental healthcare | $59M | 4 | February 2026 | Undisclosed | Venture | BakerBridge Capital | Active | Strong |
| 41 | NeuroFlow | Behavioral health workflow software | $58M | 5 | October 2022 | $25M | Series C | SEMCAP, Alumni Ventures | Active | Partial |
| 42 | Osmind | Mental health practice software | $57M | 4 | May 2022 | $40M | Series B | DFJ Growth, General Catalyst, Tiger Global | Active | Full |
| 43 | Concert Health | Primary-care behavioral health integration | $56M | 3 | April 2022 | $42M | Series B | Define Ventures, Healthy Ventures, CommonSpirit Health | Active | Strong |
| 44 | Forta | AI-enabled autism therapy | $56M | 2 | January 2024 | $55M | Series A | Insight Partners, Exor Ventures, Alumni Ventures | Active | Strong |
| 45 | Meru Health | Digital mental health clinic | $55M | 5 | September 2021 | $30M | Series B | Industry Ventures, Bold Capital Partners, Freestyle Capital | Active | Strong |
| 46 | AnswersNow | Virtual ABA autism therapy | $54M | 5 | January 2026 | $40M | Series B | HealthQuest Capital, Left Lane Capital, Owl Ventures | Active | Strong |
| 47 | firsthand | Peer-led serious mental illness care | $53M | 3 | July 2026 | $10M | Series B Extension | GV | Active | Strong |
| 48 | Freespira | Digital panic and PTSD therapy | $51M | 7 | April 2024 | $23M | Series E | Undisclosed investors | Active | Partial |
| 49 | Mindbloom | At-home clinician-guided ketamine therapy | $50M | 3 | 2021 | $35M | Series B | Kleiner Perkins, Quiet Capital, FundersClub | Active | Full |
| 50 | Affect Therapeutics | Digital substance-use and mental healthcare | $49M | 5 | September 2025 | $26M | Series B | Allumia Ventures, ARTIS Ventures, City Light Capital | Active | Partial |
| 51 | Small Pharma | DMT therapies for depression | $47M | 2 | April 2021 | $46M | RTO Equity Financing | Brokered institutional investors | Acquired | Strong |
| 52 | Amae Health | Integrated severe mental illness clinics | $46M | 5 | November 2025 | $25M | Series B | Altos Ventures, 8VC, Quiet Capital | Active | Partial |
| 53 | Iris Telehealth | Telepsychiatry provider network | $43M | 2 | April 2022 | $40M | Series B | Concord Health Partners, Columbia Pacific Advisors | Active | Full |
| 54 | Uwill | Student mental health platform | $39M | 3 | May 2023 | $30M | Series A | Education Growth Partners | Active | Strong |
| 55 | Little Otter | Family mental health care | $36M | 3 | February 2025 | $10M | Strategic Equity | Pivotal Ventures, Torch Capital, Springbank | Active | Partial |
| 56 | Array Behavioral Care | Virtual psychiatric care provider | $32M | 4 | January 2023 | $25M | Series C | CVS Health Ventures, Wells Fargo Strategic Capital, Health Velocity Capital | Acquired | Strong |
| 57 | Bend Health | Virtual pediatric behavioral health care | $32M | 2 | March 2023 | $27M | Series A | Maveron, WVV Capital, SteelSky Ventures | Acquired | Full |
| 58 | HelloSelf | Online therapy and psychological coaching | $31M | 3 | March 2023 | $20M | Series B | Octopus Ventures, OMERS Ventures, Manta Ray Ventures | Active | Strong |
| 59 | Mantra Health | Student mental health services | $31M | 3 | March 2023 | $5M | Series A Extension | VMG Partners, Alumni Ventures, Global Founders Capital | Active | Strong |
| 60 | PursueCare | Virtual addiction and mental healthcare | $31M | 4 | December 2023 | $20M | Series B | T.Rx Capital, Yamaha Motor Ventures, OCA Ventures | Active | Partial |
| 61 | SpectrumAi | Autism-care analytics and software | $29M | 2 | March 2023 | $20M | Series A | CVS Health Ventures, Cobalt Ventures, F-Prime Capital | Active | Full |
| 62 | Healios | Digital youth mental healthcare | $29M | 3 | November 2022 | $16M | Series B | Claret Capital Partners, AlbionVC, Autism Impact Fund | Active | Strong |
| 63 | OxfordVR | Automated VR psychological therapy | $27M | 3 | July 2021 | $10M | Series A Extension | Oxford Science Enterprises, Optum Ventures | Acquired | Partial |
| 64 | Nue Life Health | At-home ketamine-assisted mental-health care | $26M | 3 | June 2023 | Undisclosed | Venture Round | Obvious Ventures, Magic VC, Palm Drive Capital | Acquired | Partial |
| 65 | Marigold Health | Peer mental health recovery support | $26M | 6 | February 2026 | $0M | Convertible Note | Rock Health Capital | Active | Partial |
| 66 | Ria Health | Online alcohol use disorder treatment | $25M | 4 | February 2025 | $7M | Series B | Peloton Equity, SV Health Investors, BPEA Private Equity | Active | Partial |
| 67 | Blackbird Health | Precision youth mental healthcare | $23M | 2 | February 2024 | $17M | Series A | Define Ventures, Frist Cressey Ventures, GreyMatter | Active | Partial |
| 68 | Opya | Early-intervention autism therapy | $22M | 3 | August 2021 | $15M | Series A | Panoramic Ventures, SB Opportunity Fund, Disability Opportunity Fund | Active | Partial |
| 69 | BehaVR | VR behavioral-health digital therapeutics | $21M | 3 | December 2022 | $13M | Series B | Optum Ventures, Oxford Science Enterprises, Confluent Health | Acquired | Strong |
| 70 | Brave Health | Medicaid virtual behavioral healthcare | $21M | 2 | October 2021 | $10M | Series B | City Light Capital, Union Square Ventures, Able Partners | Active | Strong |
| 71 | Birches Health | Addiction care platform | $20M | 2 | September 2025 | Undisclosed | Series A | AlleyCorp, Will Ventures, defy.vc | Active | Partial |
| 72 | Backpack Healthcare | Medicaid-focused pediatric mental healthcare | $19M | 4 | September 2025 | $3M | Series A Extension | G2 Venture Partners, PACE Healthcare Capital | Active | Strong |
| 73 | Monument | Online alcohol treatment platform | $18M | 2 | January 2021 | $10M | Series A | VMG Catalyst, Lerer Hippeau, Collaborative Fund | Active | Full |
| 74 | Braxia Scientific | Ketamine clinics and psychedelic research | $17M | 6 | February 2023 | $1M | LIFE / Private Placement | Roger McIntyre, public investors | Shutdown | Partial |
| 75 | GrayMatters Health | Brain-biomarker mental health therapeutics | $16M | 3 | March 2023 | $2M | SAFE / Equity | EIC Fund | Active | Strong |
| 76 | Fort Health | Integrated pediatric behavioral healthcare | $14M | 2 | November 2024 | $6M | Seed II | Twelve Below, Vanterra Capital, Blue Venture Fund | Active | Partial |
| 77 | Psylo | Non-hallucinogenic neuroplastogen medicines | $14M | 3 | June 2024 | $8M | Series Seed | Palo Santo, Focalpoint Ventures, Tenmile | Active | Full |
| 78 | Awakn Life Sciences | Addiction and mental-health drug development | $12M | 4 | June 2024 | $1M | Private Placement | Undisclosed investors | Acquired | Partial |
| 79 | Journey Clinical | Therapist-led ketamine-assisted psychotherapy | $12M | 4 | January 2023 | $9M | Series A | Union Square Ventures, Fifty Years, AlleyCorp | Active | Strong |
| 80 | Manatee | Virtual therapy for families | $12M | 4 | June 2024 | $5M | Series A Extension | Grand Ventures, GreyMatter Capital | Active | Partial |
| 81 | Flow Neuroscience | At-home depression brain stimulation | $12M | 3 | August 2021 | $9M | Series A | Khosla Ventures, SwissHealth Ventures, Zühlke Ventures | Active | Strong |
| 82 | Psyomics | AI mental-health assessment technology | $11M | 6 | June 2024 | $5M | Venture / Growth Equity | Parkwalk Advisors | Active | Partial |
| 83 | Sonara Health | Remote methadone adherence care platform | $6M | 3 | August 2025 | $1M | Venture / Strategic | Boomerang Ventures, Acumen America, Sorenson Impact Foundation | Active | Partial |
| 84 | DynamiCare Health | Digital addiction recovery and incentives | $6M | 4 | March 2025 | Undisclosed | Venture Round | Halcyon Venture Partners, Hyperplane Venture Capital | Active | Partial |
| 85 | Clerkenwell Health | Psychedelic clinical research organization | $3M | 2 | October 2022 | $2M | Seed | Lionheart Ventures, Convergence Partners, Exceptional Ventures | Active | Strong |
| 86 | Innerwell | Ketamine therapy with psychotherapy | $3M | 1 | May 2022 | $3M | Pre-Seed | Greycroft, Looking Glass Capital, Max Ventures | Active | Full |

This market map, featured in our mental health market deck, highlights top companies and startups in the mental health market
Key funding trends in the mental health market
Insights
- Mental health startup funding is highly concentrated. The ten largest companies account for about $3.68B, or roughly 44% of the $8.34B tracked across the ranking.
- Psychedelic and psychedelic-adjacent mental health companies account for approximately $2.29B across 13 selected businesses, showing how capital-intensive psychiatric drug development has become compared with most care-delivery models.
- Addiction-focused mental health platforms such as Wayspring, Pelago, Workit Health, Eleanor Health, Bicycle Health, Boulder Care and Ophelia have collectively raised more than $800M, making substance-use care a major venture-backed segment.
- Digital therapeutics companies including Akili, Big Health, Click Therapeutics, Osmind, BehaVR and Flow Neuroscience raised more than $800M, yet their outcomes range from continued independence to acquisition.
- Pediatric and youth mental health startups including Brightline, InStride Health, AnswersNow, Bend Health, Healios, Backpack Healthcare and SpectrumAi collectively raised about $453M, creating a meaningful specialized funding category.
- Investor interest extends beyond consumer therapy apps. Eleos Health, Concert Health, Alma and Wayspring raised more than $560M while building infrastructure connected to providers, insurers and healthcare workflows.
- Some mental health startups have unusually concentrated capitalization. Author Health raised its entire $115M total in one financing, while Forta’s $55M Series A represents almost all of its $56M cumulative funding.
- The mental health market has a clear financing split. Psychiatric biotechnology companies often require very large rounds, while many virtual care, therapy and specialty-clinic businesses have built meaningful platforms with less than $100M.

As this chart shows, and as featured in our mental health market deck, search interest in men’s mental health has been rising steadily
A few word about our methodology
As you can see, we built a database that ranks startups in the mental health market based on their total cumulative fundraising. To create this ranking, we reviewed many sources and cross-checked information across multiple places.
Whenever possible, we prioritized official company communications, since they are the most reliable source for funding amounts. When those were not available, we relied on reputable industry sources such as TechCrunch, Crunchbase, Financial Times or Forbes (to name a few).
We excluded random blogs, unverified websites, and any sources that could not be validated.
We focused on financing that represents capital raised by mental health companies, while excluding acquisition consideration and other transactions that do not represent new primary capital when these could be identified.
When funding rounds were announced in other currencies such as euros, Swiss francs, Singapore dollars, Australian dollars, or rupees, we converted them into approximate USD equivalents for consistency.
Sometimes different sources report slightly different numbers, or the exact round size is not fully disclosed. In those cases, we flag the uncertainty and assign a confidence label to each startup, visible in the last column.
Here is what they mean.
Full confidence: The company’s equity fundraising history can be reconstructed completely from public sources. The rounds, dates, amounts, and key investors are clearly identified, with no meaningful gaps.
Strong confidence: The fundraising history is largely complete and reliable. There may be a small missing detail, such as incomplete investor information or a minor round with limited data, but the overall record is clear.
Partial confidence: The main fundraising rounds can be identified, but the record is incomplete or somewhat mixed. Some rounds may be missing or certain funding events may be difficult to separate clearly.
Low confidence: Public information is too limited, inconsistent, or ambiguous to reliably reconstruct the company’s equity fundraising history.
When the confidence level is too low, we take a conservative approach and exclude the company from the ranking. We don’t want to include data that cannot be reliably verified.
This reflects how we conduct all our research, including the work behind our report covering the mental health market.
In a world where LLMs hallucinate and unreliable information is everywhere, our goal is simple: provide data you can trust.
If you want the full detail on a specific calculation, feel free to contact us and we will gladly explain.
Finally, know that we update the dataset once per month, so come back here if you need fresh information.

This chart, featured in our mental health market deck, shows why Talkspace is winning in mental health
Related blog posts
- The most highly valued startups in the mental health market
- How strong is fundraising in the mental health market right now?
- An overview of all funding deals in the mental health market
- The main fundraising trends in the mental health market
- The evolution of funding activity in the mental health market
Who is the author of this content?
NEW MARKET PITCH TEAM
We track new markets so founders and investors can move fasterWe build living “market pitch” documents for emerging markets: from AI to synthetic biology and new proteins. Instead of digging through outdated PDFs, random blog posts, and hallucinated LLM answers, our clients get a clean, visual, always-updated view of what’s really happening. We map the key players, deals, regulations, metrics and signals that matter so you can decide faster whether a market is worth your time. Want to know more? Check out our about page. You can also follow us on Instagram or on Facebook.
How we created this content 🔎📝
At New Market Pitch, we kept seeing the same problem: when you look at a new market, the data is either missing, paywalled, or buried in 300-page reports that feel like they were written in the 80s. On the other side, LLMs and random blog posts give you confident answers with no sources, and sometimes they just make things up. That’s not good enough when you’re about to invest real money or launch a company.
So we decided to fix the experience. For each market we cover, we build a structured database and update it on a regular basis. We track funding rounds, fund memos, M&A moves, partnerships, new products, policy changes, and the real activity of startups and incumbents. Then we turn all of that into a clear “market pitch” that shows where the opportunities are and how people actually win in that space.
Every key data point is checked, sourced, and put back into context by our team. That’s how we can give you both speed and reliability: fast coverage of new markets, without the usual guesswork.